Loading...
Therapeutic Sequencing in Metastatic Renal Cell Carcinoma
The influx of multiple novel therapeutic options in the mRCC field has brought a challenge for treatment sequencing in this disease. In the past few years, cabozantinib, nivolumab and the combination of lenvatinib and everolimus have been approved in the second-line setting. As there is no direct co...
Na minha lista:
| Udgivet i: | Kidney Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
IOS Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6179120/ https://ncbi.nlm.nih.gov/pubmed/30334001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/KCA-170006 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|